NCT01310972View on ClinicalTrials.gov

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Colon Cancer
Interventions
OTHER

Registry

Registry

Trial Locations (1)

Unknown

Kfsh & Rc, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT01310972 - Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX | Biotech Hunter | Biotech Hunter